Placebo
1 clinical trial
1 product
1 indication
Clinical trial
A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Modified Ex Vivo Using Prime Editing (PM359) in Participants With Autosomal Recessive Chronic Granulomatous Disease Due to Mutations in the NCF1 GeneStatus: Not yet recruiting, Estimated PCD: 2029-09-01
Indication
Ovarian Cancer